טוען...
Sildenafil has no effect on portal pressure but lowers arterial pressure in patients with compensated cirrhosis
The reduction of portal pressure in patients with early compensated cirrhosis may be more responsive to drugs increasing intrahepatic vasodilatation than those reducing portal venous inflow. The PDE-V inhibitor sildenafil can potentially reduce portal pressure by decreasing intrahepatic resistance,...
שמור ב:
| Main Authors: | , , , , , , |
|---|---|
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
2010
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2879450/ https://ncbi.nlm.nih.gov/pubmed/20144739 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.cgh.2010.01.017 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|